Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.42 INR | -2.32% | -9.10% | -14.60% |
Valuation
Fiscal Period: March | 2023 |
---|---|
Capitalization 1 | 960 |
Enterprise Value (EV) 1 | 1,184 |
P/E ratio | 19.1 x |
Yield | 0.54% |
Capitalization / Revenue | 0.21 x |
EV / Revenue | 0.26 x |
EV / EBITDA | 7.83 x |
EV / FCF | -2.66 x |
FCF Yield | -37.6% |
Price to Book | 1.33 x |
Nbr of stocks (in thousands) | 17,203 |
Reference price 2 | 55.80 |
Announcement Date | 8/10/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 881.5 | 1,391 | 1,480 | 1,935 | 3,573 | 4,613 |
EBITDA 1 | 21.95 | 51.42 | 52.69 | 71.97 | 112.4 | 151.2 |
EBIT 1 | 21.46 | 50.06 | 49.22 | 65.74 | 104.9 | 143.1 |
Operating Margin | 2.43% | 3.6% | 3.33% | 3.4% | 2.94% | 3.1% |
Earnings before Tax (EBT) 1 | 9.888 | 32.66 | 17.16 | 35.76 | 71.91 | 94.96 |
Net income 1 | 7.398 | 23.48 | 12.75 | 26.73 | 53.04 | 70.37 |
Net margin | 0.84% | 1.69% | 0.86% | 1.38% | 1.48% | 1.53% |
EPS 2 | 1.152 | 1.860 | 0.8904 | 1.866 | 3.425 | 2.924 |
Free Cash Flow 1 | -54.49 | -88.66 | -100.5 | -97.25 | -87.85 | -444.9 |
FCF margin | -6.18% | -6.37% | -6.79% | -5.03% | -2.46% | -9.64% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | 0.3000 |
Announcement Date | 3/1/19 | 6/3/19 | 8/13/21 | 8/13/21 | 3/6/23 | 8/10/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 102 | 109 | 195 | 286 | 304 | 224 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 4.636 x | 2.123 x | 3.708 x | 3.976 x | 2.701 x | 1.481 x |
Free Cash Flow 1 | -54.5 | -88.7 | -100 | -97.2 | -87.8 | -445 |
ROE (net income / shareholders' equity) | 12.6% | 17.2% | 6.61% | 12.6% | 20.3% | 10.8% |
ROA (Net income/ Total Assets) | 5.27% | 7.72% | 5.68% | 5.23% | 5.54% | 4.84% |
Assets 1 | 140.4 | 304.3 | 224.4 | 511.4 | 957.9 | 1,455 |
Book Value Per Share 2 | 7.100 | 13.10 | 13.90 | 15.70 | 20.40 | 42.00 |
Cash Flow per Share 2 | 0.0900 | 2.490 | 0.8900 | 0.8100 | 0.1600 | 4.870 |
Capex 1 | 0.57 | 35 | 40.4 | 13.2 | 16.6 | 143 |
Capex / Sales | 0.06% | 2.51% | 2.73% | 0.68% | 0.46% | 3.11% |
Announcement Date | 3/1/19 | 6/3/19 | 8/13/21 | 8/13/21 | 3/6/23 | 8/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-14.60% | 20.49M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- 543828 Stock
- Financials Sudarshan Pharma Industries Limited